Foundations of Healthcare Economics

Introduction and Context

Healthcare economics applies economic reasoning to decisions about health, healthcare resources, and population well-being. It asks how scarce resources—such as clinicians’ time, hospital beds, medicines, diagnostic equipment, public budgets, and patients’ attention—can be allocated among competing uses. Its purpose is not to reduce health to money. Rather, it provides a disciplined way to examine trade-offs, incentives, distributional consequences, and the value created by healthcare interventions.

Healthcare managers work in an environment in which demand is substantial, resources are constrained, information is incomplete, outcomes are uncertain, and ethical obligations are prominent. A hospital may need to decide whether to expand an intensive-care unit, invest in digital diagnostics, recruit nurses, or reduce waiting times. A ministry of health may need to choose between childhood immunisation, cancer screening, primary care, and treatment of rare diseases. These are economic decisions because selecting one option generally means foregoing another.

Economic analysis complements, rather than replaces, clinical judgment, public health evidence, legal rules, and ethical reasoning. A financially inexpensive intervention is not necessarily valuable, and an expensive intervention may be justified if it produces large health gains or protects vulnerable groups. The central contribution of economics is to make the consequences and opportunity costs of choices more explicit.

Learning Objectives

By the end of this chapter, the reader should be able to:

1. Explain scarcity, choice, and opportunity cost in healthcare.
2. Distinguish efficiency from equity and identify tensions between them.
3. Apply incentives and marginal analysis to managerial decisions.
4. Distinguish positive from normative economic statements.
5. Explain why health and healthcare have distinctive economic characteristics.
6. Identify major forms of market failure in healthcare.
7. Use basic economic reasoning to evaluate healthcare policies and organisational decisions.
8. Recognise ethical, governance, and distributional issues in healthcare resource allocation.

1. Scarcity, Choice, and Opportunity Cost

Scarcity as the starting point

Scarcity means that available resources are insufficient to satisfy all wants simultaneously. Scarcity does not necessarily mean absolute shortage. Even a wealthy health system faces scarcity because it cannot provide every beneficial service to every person at the time and quality desired.

Healthcare resources include:

• financial budgets;
• professional labour and managerial time;
• medicines, equipment, and physical facilities;
• information and data-processing capacity;
• patients’ time and ability to comply with treatment;
• environmental resources and energy.

Because resources have alternative uses, every allocation decision involves choice. A hospital that uses operating-room capacity for elective surgery cannot use the same capacity at that time for another procedure. A manager who spends a day implementing a new information system cannot spend that day supervising another improvement project.

Opportunity cost

Opportunity cost is the value of the best alternative forgone when a choice is made. It is not necessarily the same as the financial price paid. If a hospital purchases a robotic surgical system for $2 million, its opportunity cost may include the clinical services, staff development, or equipment that could otherwise have been funded with those resources.

A useful general expression is:

The relevant alternative is the next-best feasible option, not every possible option. Opportunity cost may be measured in money, health outcomes, waiting time, staff well-being, or a combination of these, depending on the decision.

Worked example: opportunity cost

A district health authority has $500,000 available. It can either:

• expand a vaccination programme, expected to prevent 1,000 cases of serious illness; or
• fund a screening programme, expected to prevent 700 cases of serious illness.

If the authority chooses vaccination, the opportunity cost is the health benefit forgone from the screening programme: 700 prevented cases, subject to the assumptions and uncertainty of the estimates. If the programmes affect different kinds of health outcomes, comparison may require a common measure, such as quality-adjusted life-years (QALYs), while also considering equity and ethical concerns.

2. Efficiency and Equity

Economic efficiency

Efficiency concerns obtaining the greatest possible value from available resources or achieving a specified outcome with the least resource use. It has several forms.

Technical efficiency means producing a given output with the minimum feasible inputs, or producing the maximum output from given inputs. For example, a clinic is technically inefficient if it provides the same number and quality of consultations as another clinic while using substantially more staff hours and supplies.

Allocative efficiency means allocating resources among services so that they reflect relative benefits and costs. In a simplified model, allocative efficiency occurs when resources are directed toward uses with the greatest marginal net benefit.

Productive efficiency refers to producing output at the lowest possible cost for a given technology and input prices. Technical and productive efficiency overlap but are not identical: a technically efficient organisation may still use an unnecessarily expensive combination of inputs.

Dynamic efficiency concerns innovation and improvement over time. An organisation that minimises current costs but fails to invest in effective technology, workforce capability, or prevention may be dynamically inefficient.

Efficiency should not be interpreted narrowly as cost cutting. Reducing staff or services may lower expenditure while worsening safety, access, or outcomes. The economically relevant question is whether the value of the resources released exceeds the value of what is lost.

Equity

Equity concerns fairness in the distribution of health, healthcare access, costs, and outcomes. It is a normative concept: judgments about equity depend on values and social priorities.

Important dimensions include:

• horizontal equity: people with similar health needs receive similar treatment;
• vertical equity: people with greater needs receive appropriately different treatment;
• financial equity: payment burdens are distributed fairly according to ability to pay or need;
• geographical equity: location does not create unjustified differences in access;
• generational equity: present decisions do not unfairly burden future populations.

Efficiency and equity can support one another. Primary prevention may be both cost-effective and beneficial to disadvantaged groups. However, they can also conflict. A treatment for a rare condition may produce fewer total health gains than a broad preventive programme but may be prioritised because patients face severe illness and have few alternatives.

A sound managerial recommendation therefore identifies both efficiency consequences and distributional effects. Cost-effectiveness evidence should not be presented as a complete ethical decision rule unless society has explicitly chosen that rule.

3. Incentives and Behaviour

An incentive is a reward or penalty that influences behaviour. Prices, salaries, reimbursement systems, professional norms, waiting times, regulation, targets, and reputational effects can all create incentives in healthcare.

Examples include:

• fee-for-service payment may encourage activity and potentially over-provision;
• fixed budgets may encourage cost control but may also encourage under-provision or risk selection;
• pay-for-performance may focus attention on measurable indicators, but can produce gaming or neglect of unmeasured care;
• capitation may encourage prevention and coordination, but may create incentives to enrol healthier patients or restrict services;
• patient co-payments may reduce low-value demand, but can deter necessary care, especially among low-income patients.

Incentive analysis requires attention to the full system. A policy designed to reduce emergency-department use may unintentionally increase delayed presentations if primary care is inaccessible. Similarly, a productivity target may improve throughput while reducing time spent on communication and shared decision-making.

The principal–agent problem arises when one party, the agent, makes decisions on behalf of another party, the principal, but their interests or information differ. Patients rely on clinicians; governments rely on hospitals; boards rely on managers. Monitoring, professional standards, transparency, and appropriate contracts help align interests, but cannot eliminate all information asymmetry.

4. Marginal Analysis and Decision-Making

Marginal analysis examines the effect of a small additional change rather than the total size of a programme. Healthcare managers commonly ask whether to add one more clinic session, employ one more nurse, process one more diagnostic test, or extend a service by one hour.

The marginal benefit (MB) is the additional benefit generated by one more unit of an activity. The marginal cost (MC) is the additional cost of that unit. A simplified decision rule is:

For a continuous decision variable q, the condition for an interior optimum is:

Here, q is the quantity of service, MB(q) is marginal benefit at q, and MC(q) is marginal cost at q. The rule assumes benefits and costs can be compared using a common valuation, the decision is at the margin, and relevant effects—including externalities and distributional consequences—are considered. If benefits or costs are uncertain, expected values and risk considerations may be required.

If the additional benefit is valued at $900 and the additional cost is $700, the incremental net benefit is:

The additional unit appears worthwhile under the stated assumptions. However, the result could change if it creates a safety risk, displaces a more valuable service, or produces benefits for third parties not included in the initial calculation.

Incremental cost-effectiveness

When benefits are measured in health units rather than money, analysts may use the incremental cost-effectiveness ratio (ICER):

C₁ and C₀ are the costs of the new and existing strategies; E₁ and E₀ are their corresponding health effects. The units may be dollars per QALY, euros per life-year gained, or cost per case prevented. The denominator must represent incremental effect, not total effect. The ICER is meaningful only when the alternatives, perspective, time horizon, discounting approach, and outcome measure are clearly specified.

Economic evaluation does not mechanically determine the decision. Thresholds, budget impact, uncertainty, severity of illness, equity, and implementation feasibility also matter.

5. Positive and Normative Economics

Positive economics describes and explains what is or what is likely to occur. Examples include:

• “An increase in the price of a medicine reduced its utilisation.”
• “The new payment system increased the number of reported consultations.”

These claims can, in principle, be tested using data, although measurement and causal inference may be difficult.

Normative economics concerns what ought to occur and reflects values. Examples include:

• “Essential medicines should be free at the point of use.”
• “The health system ought to prioritise children over adults when benefits are equal.”

Normative conclusions may be informed by positive evidence but cannot be derived from evidence alone. A professional report should distinguish empirical findings from value judgments. This separation improves transparency: stakeholders can debate the evidence and the ethical premise separately.

6. The Distinctive Economic Characteristics of Health and Healthcare

Health is not identical to healthcare

Health is an outcome or state of well-being, whereas healthcare is one input into producing or maintaining health. Other inputs include income, housing, nutrition, education, employment, social relationships, environmental quality, and personal behaviour. Consequently, increasing healthcare expenditure does not automatically produce proportional improvements in population health.

A production perspective can be represented conceptually as:

The function f is not a universal numerical formula; it represents the idea that health outcomes depend on multiple interacting determinants. The relationship is context-specific and may be nonlinear.

Uncertainty and risk

Illness is uncertain in occurrence, timing, severity, and response to treatment. Patients often purchase insurance because they prefer protection against financially catastrophic losses. Insurance pools risks across people, but it also creates challenges such as moral hazard and adverse selection.

Moral hazard occurs when insurance changes behaviour because the insured person does not bear the full marginal cost of care. It may involve increased use of services or reduced preventive effort, although not all additional use is wasteful.

Adverse selection occurs when people with higher expected healthcare costs are more likely to seek or retain insurance, especially when insurers cannot accurately distinguish risks. If premiums reflect average risk, low-risk individuals may leave, raising average costs further.

Risk adjustment, mandated enrolment, subsidies, benefit design, and regulation can reduce these problems.

Information asymmetry

Healthcare markets commonly involve unequal information. Clinicians generally know more than patients about diagnosis, treatment alternatives, and prognosis. Patients may also lack the ability to assess quality even after treatment. This weakens the assumption that consumers can compare products and make fully informed choices.

Professional ethics and regulation partly address this problem, but they introduce another issue: demand may be influenced by providers. Provider-induced demand does not mean that all clinician-recommended care is inappropriate; it means that provider information and incentives can affect utilisation in ways not determined solely by patient preferences.

Externalities and public goods

An externality occurs when an action affects people who are not fully represented in the decision or transaction. Vaccination can generate positive externalities by reducing transmission to others. Air pollution can create negative health externalities. Because private decision-makers may not account for these effects, public intervention can improve social welfare.

Some public health activities have public-good characteristics: one person’s benefit does not substantially reduce another’s, and it may be difficult to exclude non-payers. Disease surveillance, epidemic preparedness, and certain environmental health measures may therefore be underprovided by private markets.

Demand for healthcare and derived demand

People generally demand healthcare because it contributes to health, not because consultations or procedures are intrinsically desirable. Healthcare demand is therefore derived from the demand for health. The relationship is influenced by illness, expected effectiveness, price, income, insurance coverage, waiting time, travel distance, culture, and trust.

The price of a service may be zero at the point of use while the real economic cost remains positive. Patients may incur taxes, premiums, travel costs, lost work time, and waiting costs. A zero monetary price does not imply unlimited resources.

Time, waiting, and quality

Healthcare is often produced and consumed simultaneously. An unused appointment slot cannot always be stored for future use. Capacity constraints create queues, and waiting is a form of rationing. A system may ration through price, waiting time, eligibility rules, clinical priority, or geography.

Quality is multidimensional. It includes effectiveness, safety, patient experience, timeliness, continuity, dignity, and equity. A narrow focus on volume may therefore misrepresent value. Managers should specify which outcomes are being measured and whether improvements in one dimension damage another.

Government involvement

Healthcare systems typically combine public financing, private provision, professional regulation, social insurance, and direct government delivery. Government involvement is justified not only by market failure but also by social preferences concerning solidarity, minimum standards, and protection from catastrophic expenditure. Yet government action can also fail through poor information, bureaucracy, political capture, weak accountability, or poorly designed incentives.

7. Market Failure in Healthcare

A market failure occurs when unregulated market decisions do not produce an outcome judged to maximise social welfare. Major sources include:

1. Externalities: for example, infectious disease transmission.
2. Information asymmetry: especially between patients and providers.
3. Uncertainty and incomplete insurance markets: some risks are difficult to insure or predict.
4. Market power: hospitals or suppliers may face limited competition in local areas.
5. Public goods: surveillance and preparedness may be underfunded privately.
6. Equity concerns: willingness to pay may not reflect morally relevant need.

Policy responses include taxation, subsidies, regulation, public provision, compulsory insurance, contracting, competition policy, information disclosure, and direct priority-setting. Each response has costs and unintended effects. For example, price regulation may improve affordability but reduce supply if prices fall below sustainable levels; competition may improve efficiency but may be difficult where quality is hard to measure or where duplication of high-cost facilities is wasteful.

8. A Framework for Healthcare Economic Decisions

A practical framework for managers is:

1. Define the decision: What must be chosen, by whom, and over what time period?
2. Specify the perspective: patient, provider, payer, government, or society.
3. Identify alternatives: include current practice and feasible substitutes.
4. Measure resources and outcomes: include relevant direct and indirect effects.
5. Consider the margin: evaluate the incremental costs and benefits of changing practice.
6. Assess uncertainty: use sensitivity analysis, scenario analysis, or probabilistic methods where appropriate.
7. Examine equity and ethics: identify who gains, who loses, and whether vulnerable groups are affected.
8. Assess implementation: consider workforce, infrastructure, regulation, and organisational capability.
9. Monitor outcomes: compare actual effects with predictions and revise decisions.

The perspective matters. A new telehealth service may increase provider costs but reduce patient travel and time away from work. A narrow hospital perspective could miss benefits visible from a societal perspective. Analysts must therefore state whose costs and benefits are included.

Applied Case: Reallocating a District Health Budget

Background

This illustrative case concerns Riverdale District, a fictional health authority serving 400,000 people. The authority has an additional annual budget of $1 million. It is considering either expanding an emergency department or funding community-based hypertension detection and management.

Problem

The emergency department is overcrowded, and the proposed expansion would add two treatment bays and extend staffing during peak hours. The primary-care proposal would fund nurses, blood-pressure devices, follow-up visits, and medicines for high-risk adults.

Analysis

The emergency expansion offers visible short-term benefits: reduced waiting times, improved patient experience, and potentially safer crowding levels. Its benefits are concentrated among people who attend the emergency department. The hypertension programme offers less visible immediate benefit but may prevent strokes, kidney disease, and avoidable admissions over several years.

The authority should compare incremental costs and outcomes rather than average costs. It should estimate:

• additional patients treated and waiting-time reduction;
• effects on safety and staff workload;
• hypertension cases detected and controlled;
• avoided strokes, admissions, and disability;
• patient travel and productivity effects;
• implementation risks and time to benefit;
• distributional effects across deprived communities.

The authority should also test whether the programmes are substitutes or complements. If emergency overcrowding is partly caused by poor access to primary care, prevention may reduce future demand. If overcrowding is driven mainly by trauma or seasonal epidemics, the prevention programme may have little short-term effect on emergency capacity.

Approach and possible solution

A balanced approach could reserve part of the budget for immediate safety-critical emergency capacity and use the remainder for a time-limited hypertension pilot in high-risk neighbourhoods. The pilot should specify baseline measures, clinical protocols, referral arrangements, equity indicators, and a review date. Evaluation should measure both health outcomes and unintended effects, such as overburdening primary-care staff.

Outcome and learning points

Suppose the pilot demonstrates improved blood-pressure control and reduced avoidable admissions, while the emergency investment substantially reduces unsafe waiting during peak periods. The appropriate conclusion is not that one service is universally superior. Rather, the case illustrates that economic decisions depend on perspective, time horizon, marginal effects, uncertainty, capacity constraints, and equity.

Key learning points are:

• visible demand is not the same as greatest social value;
• prevention may have delayed but substantial benefits;
• safety constraints can justify investment even when another programme has greater long-term health gain;
• economic evaluation should examine complementary as well as competing interventions;
• decisions should be revisited as evidence accumulates.

Ethical, Governance, and Contemporary Considerations

Economic decisions in healthcare raise ethical questions about priority, confidentiality, disability, age, severity, and discrimination. Cost-effectiveness analysis should not use crude assumptions that undervalue the lives of people with disabilities or those requiring long-term care. Quality-of-life measures must be developed and interpreted carefully, with patient and public involvement.

Governance requires transparent criteria, documented assumptions, conflict-of-interest management, auditability, and meaningful appeal or review mechanisms. Decisions should not rely solely on opaque models. Where allocation algorithms or artificial intelligence tools are used, managers should examine data quality, representativeness, bias, explainability, privacy, cybersecurity, and accountability. AI may improve forecasting and resource planning, but it does not remove the need for human judgment or ethical oversight.

Contemporary healthcare economics increasingly considers value-based care, integrated care, climate-related health costs, resilience, digital health, and the opportunity cost of workforce burnout. The economic value of prevention, continuity, and trust may be underestimated when evaluation focuses only on short-term activity. Conversely, innovation should not be adopted merely because it is technologically impressive; its incremental benefit, affordability, safety, and distributional effects must be assessed.

Limitations of Economic Reasoning

Economic models simplify reality. Health outcomes may be difficult to measure, causal effects may be uncertain, and monetary valuation can be ethically contested. Costs and benefits occurring far in the future require assumptions about discounting, while rare events can dominate decisions despite limited evidence. Organisational culture, professional identity, and political feasibility may influence results in ways that a formal model does not capture.

These limitations do not make economics irrelevant. They require humility, transparent assumptions, sensitivity analysis, stakeholder engagement, and triangulation with clinical, epidemiological, legal, and ethical evidence. The strongest decision is often not the one with the most elaborate calculation but the one whose reasoning is clear, evidence-based, contestable, and aligned with legitimate social values.

Chapter Summary

Healthcare economics studies how scarce resources are allocated among competing uses to produce health and healthcare outcomes. Scarcity makes choice unavoidable, and opportunity cost is the value of the best alternative forgone. Efficiency concerns the value or output obtained from resources, whereas equity concerns fairness in distribution; the two may reinforce or conflict with one another.

Incentives influence patients, professionals, providers, insurers, and governments. Marginal analysis compares the additional benefit and additional cost of a decision, while incremental cost-effectiveness analysis compares additional costs with additional health effects. Positive economics describes and explains observable relationships; normative economics evaluates what ought to be done.

Health is produced by healthcare and wider determinants such as income, housing, education, environment, and behaviour. Healthcare is distinctive because of uncertainty, insurance, information asymmetry, externalities, public goods, provider influence, quality variation, waiting, and ethical obligations. These characteristics create market failures and justify—but do not automatically perfect—government intervention.

Effective healthcare management requires explicit alternatives, a clearly stated perspective, incremental analysis, attention to uncertainty, equity assessment, ethical governance, and post-implementation evaluation. Economic reasoning is most valuable when used transparently alongside clinical evidence, public health knowledge, and democratic judgment.

Key Terms

Scarcity: The condition in which available resources cannot satisfy all competing wants.

Choice: Selection among alternative uses of scarce resources.

Opportunity cost: The value of the best alternative forgone by a decision.

Efficiency: Achieving the greatest feasible value or outcome from available resources.

Technical efficiency: Producing a given output with the minimum feasible inputs.

Allocative efficiency: Directing resources toward uses with the greatest relative marginal value.

Equity: Fairness in the distribution of health, healthcare, costs, and outcomes.

Incentive: A reward, penalty, or condition that influences behaviour.

Marginal benefit: The additional benefit from one more unit of an activity.

Marginal cost: The additional cost from one more unit of an activity.

Positive economics: Analysis of what is or what is likely to occur.

Normative economics: Analysis involving judgments about what ought to occur.

Information asymmetry: A situation in which parties possess unequal relevant information.

Moral hazard: Behavioural change resulting from protection against the full consequences of risk.

Adverse selection: Disproportionate enrolment of higher-risk individuals in an insurance pool.

Externality: An effect of an action on others that is not fully reflected in the transaction.

Public good: A good whose benefits are broadly non-rival and difficult to restrict to payers.

ICER: Incremental cost-effectiveness ratio, expressing additional cost per additional health effect.

Market failure: A situation in which market outcomes do not achieve the socially preferred allocation.

Derived demand: Demand for an input or service arising from demand for another outcome, such as health.

Review Questions

Short Answer Questions

1. Define opportunity cost and explain why it is relevant to a hospital investment decision.
2. Distinguish technical efficiency from equity.
3. What is the difference between marginal cost and average cost?
4. Give one example of a positive economic statement and one normative statement in healthcare.
5. Explain how information asymmetry affects the patient–provider relationship.

Long Answer Questions

1. Explain the relationship between scarcity, choice, and opportunity cost, using two healthcare examples.
2. Discuss how payment incentives can improve and unintentionally harm healthcare performance.
3. Explain the distinctive economic characteristics of healthcare and their implications for policy.
4. Compare efficiency and equity as criteria for allocating a fixed healthcare budget.
5. Describe a structured framework for evaluating a new healthcare programme.

Analytical / Application Questions

1. A hospital can use a fixed block of operating-room time for either additional cancer surgery or hip replacement. Design an economic analysis that identifies the opportunity cost, relevant marginal effects, equity issues, and data requirements.
2. A government removes all patient charges for primary care. Analyse the likely effects on utilisation, equity, provider workload, and possible moral hazard. Identify complementary policies that could reduce unintended consequences.
3. A digital triage algorithm reduces average waiting time but performs less accurately for patients who speak minority languages. Should the health system adopt it? Analyse the decision using efficiency, equity, incentives, market failure, governance, and ethical reasoning.

Multiple Choice Questions with Answers

Question 1

Which statement best defines opportunity cost?

A. The total money spent on a chosen programme

B. The value of the best alternative forgone

C. The average cost of all available programmes

D. The financial profit earned from a decision

Correct Answer: B. The value of the best alternative forgone

Question 2

A clinic produces the same number and quality of consultations as another clinic while using fewer staff hours. This most directly demonstrates greater:

A. Equity

B. Adverse selection

C. Technical efficiency

D. Moral hazard

Correct Answer: C. Technical efficiency

Question 3

A hospital should generally add an activity at the margin when:

A. Average cost is greater than total cost

B. Marginal benefit is at least as large as marginal cost

C. Total revenue is zero

D. The activity is requested by a supplier

Correct Answer: B. Marginal benefit is at least as large as marginal cost

Question 4

Which is a normative economic statement?

A. The policy increased vaccination rates by 8 percent

B. Patients travelled an average of 12 kilometres

C. The programme cost $2 million last year

D. Essential medicines should be available without financial hardship

Correct Answer: D. Essential medicines should be available without financial hardship

Question 5

Vaccination can create a positive externality because:

A. It guarantees that every vaccinated person remains healthy

B. It reduces transmission risk to other people

C. It eliminates all healthcare expenditure

D. It increases the price of unrelated services

Correct Answer: B. It reduces transmission risk to other people

Question 6

In the ICER formula, the denominator represents:

A. Total cost of the new intervention

B. Average cost per patient

C. Incremental health effect

D. The health effect of the existing intervention only

Correct Answer: C. Incremental health effect

Question 7

Which situation is an example of adverse selection?

A. An insured patient uses more care because insurance lowers the point-of-use price

B. A hospital adopts a safer surgical checklist

C. People with high expected healthcare costs are more likely to buy insurance

D. A government funds disease surveillance

Correct Answer: C. People with high expected healthcare costs are more likely to buy insurance

Question 8

Healthcare demand is often described as derived demand because patients seek healthcare primarily to:

A. Increase the number of hospital buildings

B. Obtain health or prevent health loss

C. Increase provider market power

D. Eliminate all uncertainty from life

Correct Answer: B. Obtain health or prevent health loss

Question 9

A decision that maximises total health gains but substantially disadvantages a deprived population raises a central tension between:

A. Positive and negative externalities

B. Technical and dynamic efficiency

C. Efficiency and equity

D. Demand and supply measurement

Correct Answer: C. Efficiency and equity

Question 10

Which statement best reflects the role of economic evaluation in healthcare?

A. It automatically determines the ethically correct decision

B. It replaces clinical judgment and public participation

C. It makes costs, outcomes, trade-offs, and assumptions more explicit

D. It proves that the cheapest intervention is always best

Correct Answer: C. It makes costs, outcomes, trade-offs, and assumptions more explicit